GGrantIndex
← Leaderboards

Lynda Elizabeth Polgreen

University Of Minnesota

$1,352,689
Attributed
$1,352,689
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $205.2K · FY200818
$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$1,352,689 · 5

By mechanism

U54$802,543 · 2
K23$533,691 · 1
M01$16,455 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Child

Research focus

ChildBoneMinnesotaBone DiseasesPeripheralHeightLongitudinal StudiesComputersTomographyUniversitiesGrowthBone HealthOsteoporosisBone DensityBone TurnoverMeasurementUtahFutureChildhoodKyphosis Deformity Of SpineEvaluationAdultLaboratoriesDysplasia

Grant awards (17)

Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: A Multi-Center Study of the Lysosomal Disease Network$96,011
U54 · FY2018 · NS · contact PI
Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: A Multi-Center Study of the Lysosomal Disease Network$96,011
U54 · FY2017 · NS · contact PI
Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: A Multi-Center Study of the Lysosomal Disease Network$96,010
U54 · FY2016 · NS · contact PI
Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: A Multi-Center Study of the Lysosomal Disease Network$96,011
U54 · FY2015 · NS · contact PI
Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: A Multi-Center Study of the Lysosomal Disease Network$95,020
U54 · FY2014 · NS · contact PI
Natural History of Bone Disease and the Impact of Growth Hormone Treatment in MPS$134,973
K23 · FY2013 · AR · contact PI
Longitudinal Study of Bone Disease and the Impact of Growth Hormone Treatment$61,923
U54 · FY2013 · NS · contact PI
Natural History of Bone Disease and the Impact of Growth Hormone Treatment in MPS$1,000
K23 · FY2013 · AR · contact PI
Natural History of Bone Disease and the Impact of Growth Hormone Treatment in MPS$134,973
K23 · FY2012 · AR · contact PI
Longitudinal Study of Bone Disease and the Impact of Growth Hormone Treatment$61,948
U54 · FY2012 · NS · contact PI
Natural history of bone disease and the impact of growth hormone treatment in MPS$132,915
K23 · FY2011 · AR · contact PI
Longitudinal Study of Bone Disease and the Impact of Growth Hormone Treatment$62,421
U54 · FY2011 · NS · contact PI
Natural history of bone disease and the impact of growth hormone treatment in MPS$129,830
K23 · FY2010 · AR · contact PI
Longitudinal Study of Bone Disease and the Impact of Growth Hormone Treatment$75,383
U54 · FY2010 · NS · contact PI
Longitudinal Study of Bone Disease and the Impact of Growth Hormone Treatment$61,805
U54 · FY2009 · NS · contact PI
BONE MINERAL RESORPTION IN CHILDREN AFTER HEMATOPOIETIC CELL TRANSPLANTATION$5,854
M01 · FY2009 · RR · contact PI
BONE MINERAL RESORPTION IN CHILDREN AFTER HEMATOPOIETIC CELL TRANSPLANTATION$10,601
M01 · FY2008 · RR · contact PI